Showing results (2061-2070 of 3,237) with videos related to
Sort By:
Pageof 324
The Journal of Chemical Physics|June 24, 2010
The irradiation of ammonia ice studied by near edge x-ray absorption spectroscopyPh Parent, F Bournel, J Lasne, et al.Discovery Medicine|February 5, 2013
Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical backgroundTamas Fulop, Guy Lacombe, Stephen Cunnane, et al.Hemodialysis International. International Symposium on Home Hemodialysis|August 29, 2012
Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept studyMichèle Kessler, Concetta Gangemi, Alberto Gutierrez Martones, et al.European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 26, 2021
Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRYAntoine Asquier-Khati, Wladimir Mauhin, Guillaume Michel, et al.Leukemia|September 1, 1995
Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?H Dombret, S Geiger, M T Daniel, et al.Biochimica Et Biophysica Acta|October 6, 2010
Different membrane behaviour and cellular uptake of three basic arginine-rich peptidesAstrid Walrant, Isabelle Correia, Chen-Yu Jiao, et al.Science Signaling|May 7, 2015
Nitrate sensing and uptake in Arabidopsis are enhanced by ABI2, a phosphatase inactivated by the stress hormone abscisic acidSophie Léran, Kai H Edel, Marjorie Pervent, et al.European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.Journal of Medical Genetics|December 1, 1998
Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotypeM Longy, V Coulon, B Duboué, et al.Pageof 324